Tag: Reaffirmed
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat
GeneDx Holdings Corp. (NASDAQ:WGS) has emerged as one of the top digital health stocks to invest in currently.…
Mizuho Raised Waystar Target to $50, Reaffirmed Outperform After Q3 Strength
Waystar Holding Corp. (NASDAQ:WAY) has emerged as one of the best digital health stocks to consider adding to…
ServiceTitan (TTAN) Stock Reaffirmed Overweight on Expanding AI Opportunities
ServiceTitan Inc. (NASDAQ: TTAN) continues to make waves in the technology and AI sectors with its innovative approaches…